I am also a reasonably large and long term holder and I want to say that it wasn't that long ago that $8 per share was looking like an incredible outcome. The FDA approval of Trofinetide is obviously an important factor but until that comes through then we can't be 100% sure that it does.
I'm my experience Little T has been one of the valuable long term contributors to this forum and has proven over and over that his advice is well worth noting.
I don't see anyone saying that the share price won't be $16 or more but I do see sensible people trying to keep it real
Share Price, page-963
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.74 |
Change
-0.435(2.16%) |
Mkt cap ! $2.543B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.45 | $19.74 | $1.947M | 97.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 308 | $19.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.74 | 7 | 3 |
View Market Depth
| Last trade - 14.15pm 29/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |